Department / Division:
Medicine / Cardiology

Address:
2400 Pratt Street, Room 7028
Durham, NC 27705

Appointment Telephone:
919-681-5816

Office Telephone:
919-668-8749

Fax Telephone:
919-668-7072

• MD, Tufts University School of Medicine (Massachusetts), 1986

• Internal Medicine, University of Massachusetts Medical Center, 1986-1990
• Cardiology, Duke University Medical Center, 1990-1993

Clinical Interests:
Interventional cardiology (PTCA), ischemic heart disease, acute coronary care, cardiovascular clinical trials

Research Interests:
Robert A. Harrington, MD is the Director of the Duke Clinical Research Institute (DCRI).  His research interests include evaluating antithrombotic therapies to treat acute ischemic heart disease and to minimize the acute complications of percutaneous coronary procedures, studying the mechanism of disease of the acute coronary syndromes, understanding the issues of risk stratification in the care of patients with acute ischemic coronary syndromes, trying to better understand and improve upon the methodology of clinical trials. He is the recipient of an NIH Roadmap contract to investigate “best practices” among clinical trial networks.

He has authored multiple peer-reviewed manuscripts, reviews, book chapters, and editorials. He is one of the senior co-editors for the 8th edition of the American College of Chest Physicians’ Consensus Panel on Antithrombotic and Thrombolytic Drugs and co-edited the textbook, Antiplatelet Therapy in Clinical Practice. He is an Associate Editor of the American Heart Journal and an editorial board member for the Journal of the American College of Cardiology. He is a Fellow of the American College of Cardiology, the American Heart Association, the Society of Cardiovascular Angiography and Intervention and the American College of Chest Physicians. He is currently a member of the Board of Trustees of the American College of Cardiology and chairs the American College of Cardiology Clinical Expert Consensus Document Task Force and the Education Strategy Committee. He chaired the 2006 Annual Scientific Sessions for the American College of Cardiology. He currently serves as a member of the FDA Cardiovascular and Renal Drugs Advisory Committee, a member of the NHLBI’s study section for clinical trials and is a member of the NHLBI Working Group on Clinical Trials Methodology.